Boston Scientific Corporation
Boston Scientific Corporation
Explore linked clinical trials.148 results · Page 1 of 6
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Not applicable | 2026-10-09 | NCT07867886 | |
| Atrial Remodeling After PFA Substrate Modification for Persistent AF (PeAF) | Arrhythmias, Cardiac, Atrial Remodeling, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, persistent atrial fibrillation | Enrolling by invitation | Not applicable | 2026-10-09 | NCT07675395 | |
| Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain | Back Pain, Low Back Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Vertebrogenic Pain Syndrome | Recruiting | Not stated | 2026-10-09 | NCT06827262 | |
| Paresthesia-Free Fast-Acting Subperception (FAST) Study | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Active, not recruiting | Not applicable | 2026-10-09 | NCT04618471 | |
| A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bone disorder, lumbar spinal stenosis, musculoskeletal system disorder, spinal stenosis, vertebral column disorder | Active, not recruiting | Not applicable | 2026-10-09 | NCT04192591 | |
| Patient Retrospective Outcomes (PRO) | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not stated | 2026-10-09 | NCT01550575 | |
| Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up | Arrhythmia, Sinus, Arrhythmias, Cardiac, Bradycardia, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sinus Node Dysfunction, atrioventricular block, atrioventricular dissociation, cardiovascular disorder, heart disorder, progressive familial heart block, type 1A, sick sinus syndrome | Recruiting | Not stated | 2026-10-07 | NCT07209852 | |
| Safety and Effectiveness of Orbera365™ Intragastric Balloon System | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not stated | 2026-10-07 | NCT07062094 | |
| Deep Brain Stimulation (DBS) Retrospective Outcomes Study | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, dystonic disorder, essential tremor, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2026-10-07 | NCT03664609 | |
| Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) | Arrhythmias, Cardiac, Blood Protein Disorders, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Ventricular Dysfunction, Ventricular Dysfunction, Left, breast cancer, breast disorder, breast neoplasm, cancer, cardiovascular disorder, heart disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, injury, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, radiation injury, skin disorder, vascular disorder, vascular hemostatic disease | Not yet recruiting | Not applicable | 2026-10-06 | NCT07776964 | |
| Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-10-05 | NCT07069738 | |
| Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics | Device Related Thrombosis; Peri-device Leak | Recruiting | Not applicable | 2026-10-05 | NCT06523166 | |
| Insula Neuromodulation for Chronic Neuropathic Pain | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Not applicable | 2026-10-05 | NCT05404581 | |
| WATCHMAN FLX Pro European Registry | Left Atrial Appendage Closure; Non-valvular Atrial Fibrillation (AF) | Active, not recruiting | Not stated | 2026-10-02 | NCT07262255 | |
| Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiovascular disorder, heart disorder, ventricular tachycardia | Active, not recruiting | Not applicable | 2026-10-02 | NCT04798768 | |
| A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning. | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Not stated | 2026-10-01 | NCT07669727 | |
| CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction) | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Not yet recruiting | Not applicable | 2026-10-01 | NCT07254455 | |
| TheraSphere With Durvalumab and Tremelimumab for HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-10-01 | NCT05063565 | |
| PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II) | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, persistent atrial fibrillation | Recruiting | Not applicable | 2026-09-29 | NCT07106970 | |
| AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions | Coronary Arterial Disease (CAD); de Novo Lesions in Native Coronary Arteries | Recruiting | Not applicable | 2026-09-29 | NCT06959524 | |
| A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism | Acute Pulmonary Embolism | Recruiting | Not stated | 2026-09-29 | NCT06819865 | |
| A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Not yet recruiting | Not applicable | 2026-09-28 | NCT07820930 | |
| Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device | cancer, chromosome 2q32-q33 deletion syndrome, neoplasm | Active, not recruiting | Not applicable | 2026-09-28 | NCT06192758 | |
| A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-09-28 | NCT05303467 | |
| A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population | Arterial Occlusive Diseases, brain disorder, cardiovascular disorder, carotid artery disorder, carotid stenosis, central nervous system disorder, cerebrovascular disorder, nervous system disorder, vascular disorder | Not yet recruiting | Not stated | 2026-09-25 | NCT07458243 |